N6-(Bis(ethylamino)methylene)-D-lysine is a modified lysine derivative introducing a bis(ethylamino) moiety for enhanced cationic character. The structural change supports studies of polyamine-like interactions and nucleic-acid binding. Researchers evaluate its conformational behavior and reactivity. Applications include peptide modification, charge-tuning studies, and polycationic motif design.
CAT No: R2593
CAS No:98500-82-4
Synonyms/Alias:N6-(Bis(ethylamino)methylene)-D-lysine;98500-82-4;D-Diethyl-homoarginine;BD645UH6BV;(2R)-2-amino-6-[bis(ethylamino)methylideneamino]hexanoic Acid;UNII-BD645UH6BV;D-Lysine, N6-(bis(ethylamino)methylene)-;N6-((Ethylamino)(ethylimino)methyl)-D-lysine;N6-?[Bis(ethylamino)?methylene]?-D-?lysine;FD164027;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.